Similarly, loss of FGL1 induced EMT in lung cancer [25], and expression of FGL1 in circulating tumor cells (CTCs) indicated poor prognosis in hepatocellular carcinoma (HCC) [26]. This evidence concerns the gene FGL1 and lung cancer.